Spartan Bioscience Targeting Alzheimer's Drug Trials With New Near-Patient APOE Test

Jul 27, 2016

|

Premium

NEW YORK (GenomeWeb) – After launching the "world's smallest" PCR-based diagnostic device less than two months ago, Spartan Bioscience this week announced the first official test on the system — a 30-minute cheek swab assay for mutations in the apolipoprotein E (APOE) gene.

The target market for the research-use only test is pharmaceutical companies, to help focus and speed up Alzheimer's disease-related clinical trials, Spartan's CEO Paul Lem said in an interview.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

GEDmatch Opts Outs

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

Noisy Signal

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

For All the Cute Doggos

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

This Week in PNAS

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.

Jun

17

Featured Webinar

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Menu